UK Stocks-Factors to watch on Feb 2



Feb 2 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening 57 points higher at 7,524.5 on Wednesday, according to financial bookmakers.

* SHELL: Shell SHEL.L said on Tuesday it was re-routing oil supplies to other depots following a cyberattack on two subsidiaries of German logistics firm Marquard & Bahls this week.

* GSK: GlaxoSmithKline GSK.L announced a settlement worth $1.25 billion between its ViiV Healthcare and Gilead Sciences Inc GILD.O on Tuesday in relation to patent violations by Gilead's Biktarvy, a medicine to treat human immunodeficiency virus.

* ECONOMY: British shoppers were hit by the biggest increase in prices charged by major retailers in more than nine years in January, according to a survey that added to signs of accelerating inflation momentum.

* METALS: Copper ticked up as the dollar remained restrained after recently tumbling from a 19-month peak, but the absence of Chinese onshore traders due to the week-long Lunar New Year holiday kept Asian trading range-bound and volumes thin.

* OIL: Oil prices climbed toward last week's seven-year highs as a draw in U.S. crude stocks confirmed strong demand and a lack of supply, but investors remained cautious ahead of an OPEC+ meeting later in the day.

* GOLD: Gold was steady above the $1,800 psychological level as concerns surrounding Ukraine supported the safe-haven metal, while investors awaited U.S. jobs data that is considered key for the Federal Reserve's tapering timeline.

* Mining and bank stocks supported London's FTSE 100 on Tuesday as metal prices and bond yields rose ahead of a widely anticipated Bank of England meeting later in the week.

* UK CORPORATE DIARY: Severn Trent

SVT.L Q3 Trading Update Vodafone

VOD.L Q3 Trading Update Glencore

<GLEN.L FY production update

>

* For more on the factors affecting European stocks, please click on:

TODAY'S UK PAPERS

> Financial Times

> Other business headlines


Reporting by Sinchita Mitra in Bengaluru

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.